Novartis focuses on the research and development of innovative drugs and the search for new treatment methods. Its many innovations make it one of the most successful pharmaceutical companies in the world.

The Innovative Medicines division is divided into two business units: Pharmaceuticals and Oncology. Both focus on bringing patented medicines to patients in the Czech Republic, in the following domains:

• Neurology,
• Cardiovascular and Metabolic diseases,
• Dermatology,
• Immunology,
• Transplant Medicine,
• Rheumatology,
• Pneumonology,
• Ophthalmology,
• Respiratory Diseases,
• Oncological Diseases.

The Sandoz division manufactures affordable and high-quality generic drugs and biosimilars. For more information about Sandoz, click here [2].

You can find additional information in Therapeutic Areas of Novartis [3].

For our global product portfolio, click here [4].